Technical Assistance

Review of standards, procedures and training guidelines f...

Review of standards, procedures and training guidelines for the effective roll-out of injectable PrEP

See all assistances

calendar logo svg

Context:

HIV remains a major public health issue in Guinea, despite the progress made in combating the epidemic. In 2024, around 130,000 people were living with HIV,

and prevalence was estimated at 1.3 per cent among adults aged 15 to 49. The epidemic is concentrated amongst key populations and their networks, with particularly high prevalence rates amongst men who have sex with men (MSM, 9.8 per cent), sex workers (4.9 per cent) and people who inject drugs (PWID, 3.6 per cent). These populations continue to face numerous barriers to accessing prevention and testing services, notably stigma, discrimination and socio-cultural or legal constraints.

In this context, pre-exposure prophylaxis (PrEP) is a key tool for diversifying prevention strategies and addressing the specific needs of key populations. As part of the Global Fund’s GC7 grant and thanks to funding from the Expertise France Initiative, between 2024 and 2026 Solthis supported the National Programme to Combat HIV/AIDS and Viral Hepatitis (PNLSH) and the lead grantee (PR) Plan International Guinea in the introduction and roll-out of oral PrEP. This support enabled the development of a tailored service offering and the launch of its implementation across six regions and thirteen sites in 2025. The evaluation of the pilot phase, carried out in early 2026, confirmed the relevance of the strategy and recommended its scaling up to the national level from 2027.

The arrival of Lenacapavir, a long-acting injectable PrEP administered twice a year, opens up new possibilities for reaching the hardest-to-reach populations. However, its introduction requires the adaptation of standards and procedures, as well as training guidelines, prior to its planned roll-out in 2028 under the GC8 grant. With this in mind, the second phase of technical assistance provided by Solthis and L’Initiative aims to support the PNLSH and Plan International Guinea in integrating this new prevention option into the national PrEP strategy.

 

General objective:

To support and assist the National Programme to Combat HIV and Hepatitis in preparing for the introduction of injectable PrEP and its planned roll-out under the Global Fund’s GC8 grant.

 

Specific objectives:

SO1: develop and validate national standards and procedures for PrEP for key populations, incorporating injectable PrEP, and ensure these are validated

SO2 : develop and validate new training guidelines incorporating injectable PrEP

SO3: make available the updated, detailed and budgeted implementation plan for injectable Lenacapavir PrEP

SO4: establish a pharmacovigilance mechanism for Lenacapavir and a system for monitoring drug resistance

Intervention area

Guinea

FINANCING
Description longue indisponible.